Time filter

Source Type

Sas-Korczynska B.,Klinika Nowotworow Piersi i Klatki Piersiowej Centrum Onkologii | Martynow D.,Klinika Nowotworow Piersi i Klatki Piersiowej Centrum Onkologii | Korzeniowski S.,Klinika Nowotworow Piersi i Klatki Piersiowej Centrum Onkologii
Nowotwory | Year: 2013

Breast cancer is a rare disease in men and accounts for less than 1% of all male cancers. Male have a worse prognosis than females with breast cancer. This paper reports on 81 males with breast cancer who received therapy during 50 years (1960-2010) at the Cancer Centre in Krakow. The aim was to study the influence of some clinical and therapeutic factors on treatment results. Material and methods: This group of 81 men with breast cancer accounts for only 0.5% of all patients with breast cancer who were treated at the Cancer Centre in Krakow in this period of time. Patient's ages were from 34 to.


Sas-Korczynska B.,Klinika Nowotworow Piersi i Klatki Piersiowej Centrum Onkologii | Mitus J.,Klinika Chirurgii Onkologicznej | Stelmach A.,Klinika Chirurgii Onkologicznej | Rys J.,Zaklad Patologii Nowotworow | Wlodarczyk E.,Klinika Nowotworow Piersi i Klatki Piersiowej Centrum Onkologii
Nowotwory | Year: 2013

Introduction. Tubular breast cancer accounts for approximately 1% to 2% of all invasive breast cancer types. It is composed of well-differentiated tubular structures which are lined by a single layer of epithelial cells. The purpose of this study is to present the clinical characteristics and treatment outcomes of 67 patients treated for tubular breast cancer at the Oncology Centre in Krakow between 1955 and 2002. Material and methods. Stage I or II cancer was found in 62 patients (92.5%) of the total group. In 43 cases (64.2%) the size of the breast tumor was 2 cm or less. In 52 patients (77.6%) no axillary lymph node metastasis was observed. Surgery was used as primary method of therapy in all patients. Mastectomy was performed in 60 patients and 7 patients underwent breast conserving surgery. Post-operative radiotherapy was received by 13 patients. Systemic treatment such as chemotherapy and hormonal therapy were also performed. Results. The maximum follow-up period was 320 months. 10-year survivals were as follows: 83.8% (overall survival) and 91.6% (disease-free survival). During the follow-up 2 patients (3%) developed local recurrence and in 5 patients (7.5%) distant metastases were observed. A second primary cancer was found in 8 patients (11.9%). Conclusions. Outcomes confirm good prognosis in patients treated with tubular breast cancer. There is possibility of early diagnosis and this will enable the provision of breast conserving treatment. This is a very important factor influencing quality of life in patients with breast cancer. © Polskie Towarzystwo Onkologiczne.

Loading Klinika Nowotworow Piersi i Klatki Piersiowej Centrum Onkologii collaborators
Loading Klinika Nowotworow Piersi i Klatki Piersiowej Centrum Onkologii collaborators